The definition of valvular and non-valvular atrial fibrillation: results of a physicians' survey

被引:58
|
作者
Molteni, Mauro [1 ]
Friz, Hernan Polo [1 ]
Primitz, Laura [1 ]
Marano, Giuseppe
Boracchi, Patrizia
Cimminiello, Claudio [1 ]
机构
[1] Vimercate Hosp, Div Internal Med, Dept Med, I-20871 Vimercate, Italy
来源
EUROPACE | 2014年 / 16卷 / 12期
关键词
Atrial fibrillation; Valvular; Non-valvular; Anti-thrombotic therapy; Stroke; Survey; 2010 ESC GUIDELINES; EUROPEAN-SOCIETY; MEMBER COUNTRIES; WARFARIN; MANAGEMENT; RIVAROXABAN; DABIGATRAN; APIXABAN; STROKE;
D O I
10.1093/europace/euu178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To assess different aspects of the definition of valvular/non-valvular atrial fibrillation (AF) used in clinical practice by physicians who usually treat this condition. Methods and results We prospectively conducted a web-based survey including cardiologists and internists who attended continuing medical education courses on cardiovascular medicine. A questionnaire was drawn up, containing 17 questions clustered into five main topics: (A) known rheumatic aetiology; (B) site/type of valve involvement; (C) prosthetic heart valve; (D) haemodynamic relevance; (E) miscellaneous. The overall response rate was 22.4%(21.1% for cardiologists and 24% for internists). Coexistence of both medical history of rheumatic disease and clinical signs of valvular involvement were considered as essential prerequisites for the diagnosis of rheumatic AF by half of the respondents, and one-third assumed that lone aortic valve disease was sufficient for AF to be defined as valvular. A similar proportion of respondents considered that in the presence of mitral regurgitation, AF had to be defined as valvular. The majority of responding physicians considered the degree of valvular defect of lesser importance for the definition of valvular or non-valvular origin of AF. Conclusion We found important heterogeneity and uncertainties in the answers given by physicians who usually treat patients with AF, as evidence of the lack of precise and unique definitions of the origin of AF (valvular/non-valvular). It is urgent to issue clear widely accepted definitions of the origin of AF, which should improve clinical practice and research.
引用
收藏
页码:1720 / 1725
页数:6
相关论文
共 50 条
  • [1] Novel Anticoagulants for Non-valvular Atrial Fibrillation
    Xu, Bo
    Whitbourn, Robert
    HEART LUNG AND CIRCULATION, 2012, 21 (08) : 463 - 467
  • [2] Impact of valvular heart disease on oral anticoagulant therapy in non-valvular atrial fibrillation: results from the RAMSES study
    Basaran, Ozcan
    Dogan, Volkan
    Beton, Osman
    Tekinalp, Mehmet
    Aykan, Ahmet Cagri
    Kalaycioglu, Ezgi
    Bolat, Ismail
    Tasar, Onur
    Safak, Ozgen
    Kalcik, Macit
    Yaman, Mehmet
    Inci, Sinan
    Altintas, Bernas
    Kalkan, Sedat
    Kirma, Cevat
    Biteker, Murat
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (02) : 157 - 165
  • [3] Novel oral anticoagulants in non-valvular atrial fibrillation
    Potpara, Tatjana S.
    Lip, Gregory Y. H.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 115 - 129
  • [4] New anticoagulants in patients with non-valvular atrial fibrillation
    Zellerhoff, S.
    Lewalter, T.
    Eckardt, L.
    Treszl, A.
    Wegscheider, K.
    Breithardt, G.
    NERVENHEILKUNDE, 2012, 31 (11) : 813 - 820
  • [5] Warfarin in non-valvular atrial fibrillation
    Dalby, A. J.
    Wessels, P.
    Opie, L. H.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2013, 103 (12): : 901 - 904
  • [6] Novel Anticoagulants in Prevention of Cardioembolic Stroke in Patiens with Non-Valvular Atrial Fibrillation
    Bauer, Jiri
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2013, 76 (05) : 550 - 558
  • [7] Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation
    Masotti, Luca
    Di Napoli, Mario
    Ageno, Walter
    Imberti, Davide
    Becattini, Cecilia
    Paciaroni, Maurizio
    Godoy, Daniel Augustin
    Cappelli, Roberto
    Landini, Giancarlo
    Panigada, Grazia
    Iori, Ido
    Prisco, Domenico
    Agnelli, Giancarlo
    ITALIAN JOURNAL OF MEDICINE, 2013, 7 : 8 - 21
  • [8] Newer Anticoagulants for Non-Valvular Atrial Fibrillation
    Harburger, Joseph M.
    Aronow, Wilbert S.
    PHARMACEUTICALS, 2012, 5 (05) : 469 - 480
  • [9] Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients
    Deitelzweig, Steven
    Keshishian, Allison
    Kang, Amiee
    Dhamane, Amol D.
    Luo, Xuemei
    Balachander, Neeraja
    Rosenblatt, Lisa
    Mardekian, Jack
    Jiang, Jenny
    Yuce, Huseyin
    Lip, Gregory Y. H.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [10] Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
    Singh, Sheldon M.
    Wijeysundera, Harindra C.
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (08)